STOCK MARKET BSE NSE

Dabur plans subscription-based model for ayurvedic medicines

In a subscription-based model, consumers receives products from a company at a regular interval.

Published: 26th September 2017 04:03 PM  |   Last Updated: 26th September 2017 04:03 PM   |  A+A-

By PTI

NEW DELHI: Homegrown FMCG major Dabur is testing a subscription-based model for its ayurvedic medicines in the country, a senior company official said today.

"Subscription-based model is the future for healthcare. It is in pilot stage right now. It is a good experiment which we are doing," Dabur India Executive Director (Consumer Care Business) Krishan Kumar Chutani told reporters here.

Chutani also hinted that the company will open clinics with Ayurveda doctors to advise patients. He, however, refused to share details.

In a subscription-based model, consumers receives products from a company at a regular interval.

When asked if the company plans to set up its own clinics: "You are asking me is future, I will not be able to reveal but somewhere in that direction. Telemedicine and eventually getting into the entire ecosystem of ayurvedic doctors is what we want to own".

The company recently started a new service called Ask Dabur where a panel of doctors answer consumers' questions.

He did not elaborate that in which city the company doing the pilot project.



Comments

Disclaimer : We respect your thoughts and views! But we need to be judicious while moderating your comments. All the comments will be moderated by the newindianexpress.com editorial. Abstain from posting comments that are obscene, defamatory or inflammatory, and do not indulge in personal attacks. Try to avoid outside hyperlinks inside the comment. Help us delete comments that do not follow these guidelines.

The views expressed in comments published on newindianexpress.com are those of the comment writers alone. They do not represent the views or opinions of newindianexpress.com or its staff, nor do they represent the views or opinions of The New Indian Express Group, or any entity of, or affiliated with, The New Indian Express Group. newindianexpress.com reserves the right to take any or all comments down at any time.

flipboard facebook twitter whatsapp